A Phase 2 Open-Label, parallel Group, Randomized Dose-Finding Study to Assess the Efficacy and safety on Intecostal SKY0402 in Subjects Undergoing Posterolateral Thoracotomy

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/0910/31/09

Funding

  • Pacira Pharmaceuticals: $3,150.00